USPTO Examiner CHEEMA UMAR - Art Unit 2458

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18657635Network Health Monitor Within A Coarse Grained Reconfigurable Architecture ProcessorMay 2024June 2025Allow1300NoNo
18647854CONNECTING SERVICE LEVEL OUTPUTS TO ORCHESTRATION INPUTSApril 2024August 2025Allow1510YesNo
18644310OPEN RADIO ACCESS NETWORK CLOUD INTELLIGENT CONTROLLERApril 2024November 2025Allow1810YesNo
18620157NETWORK MANAGEMENT METHOD AND APPARATUSMarch 2024June 2025Allow1400YesNo
18408547DETERMINING INFORMATION RELATED TO A DESIGNATED DATA TRANSMISSION RATE FOR A WIRELESS LINKJanuary 2024February 2026Allow2520NoNo
18561737APPLYING MANAGEMENT CONSTRAINTS DURING NETWORK SLICE DESIGNNovember 2023December 2025Allow2510NoNo
18466195OPAQUE ROUTING ON OVERLAY NETWORKS: A STRUCTURED NEURAL NET BASED APPROACHSeptember 2023February 2026Allow2910YesNo
18364457RACH BASED ON FMCW CHANNEL SOUNDINGAugust 2023August 2025Allow2500NoNo
18349934SCHEDULING TRANSMISSION METHOD AND APPARATUSJuly 2023November 2025Allow2810NoNo
18103040USING NETWORK WATERFALL DATA TO ASSESS THE QOE OF WEB-BASED APPLICATIONSJanuary 2023February 2026Allow3630YesNo
17921295METHOD FOR ASSOCIATING ACTIONS FOR INTERNET OF THINGS, ELECTRONIC DEVICE AND STORAGE MEDIUMOctober 2022December 2025Allow3720NoNo
17952069DATA PROCESSING METHOD AND DEVICESeptember 2022December 2025Allow3910NoNo
17877816BEACON AND THREAT INTELLIGENCE BASED APT DETECTIONJuly 2022January 2025Allow3010YesNo
17496062COT Indication Information Sending Method and ApparatusOctober 2021February 2025Allow4020NoNo
13450633MIGRATING ACTIVE I/O CONNECTIONS WITH MIGRATING SERVERS AND CLIENTSApril 2012July 2014Allow2630NoYes
13038801SYSTEM AND METHOD FOR GLOBALLY AND SECURELY ACCESSING UNIFIED INFORMATION IN A COMPUTER NETWORKMarch 2011February 2016Allow6030YesYes
11821101Providing treatment-indicative feedback dependent on putative content treatmentJune 2007July 2014Allow6070YesYes

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner CHEEMA, UMAR.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
0
(0.0%)
Examiner Reversed
1
(100.0%)
Reversal Percentile
93.3%
Higher than average

What This Means

With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
3
Allowed After Appeal Filing
2
(66.7%)
Not Allowed After Appeal Filing
1
(33.3%)
Filing Benefit Percentile
91.6%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 66.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner CHEEMA, UMAR - Prosecution Strategy Guide

Executive Summary

Examiner CHEEMA, UMAR works in Art Unit 2458 and has examined 4 patent applications in our dataset. With an allowance rate of 100.0%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 10000 months.

Allowance Patterns

Examiner CHEEMA, UMAR's allowance rate of 100.0% places them in the 95% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by CHEEMA, UMAR receive 3.75 office actions before reaching final disposition. This places the examiner in the 96% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by CHEEMA, UMAR is 10000 months. This places the examiner in the 0% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +0.0% benefit to allowance rate for applications examined by CHEEMA, UMAR. This interview benefit is in the 13% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 37.5% of applications are subsequently allowed. This success rate is in the 85% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 75.0% of appeals filed. This is in the 64% percentile among all examiners. Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 15% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 19% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.